Armando Arredondo
National Institute of Public Health
Cuernavaca
Morelos
Mexico
Name/email consistency: high
- Hospitalization costs associated with hypertension as a secondary diagnosis. Arredondo, A. Am. J. Hypertens. (2010)
- Equity, governance and financing after health care reform: lessons from Mexico. Arredondo, A., Orozco, E. Int. J. Health. Plann. Manage (2008)
- Out-of-pocket costs to users: medicine options for hypertension. Arredondo, A. Am. J. Hypertens. (2008)
- Equity and accessibility in health? Out-of-pocket expenditures on health care in middle income countries: evidence from Mexico. Arredondo, A., Nájera, P. Cad. Saude. Publica (2008)
- Economic burden of expected epidemiological changes in diseases related to tobacco, Mexico. Arredondo, A., Carrillo, C., Zuñiga, A. Rev. Saude. Publica (2007)
- Effects of health decentralization, financing and governance in Mexico. Arredondo, A., Orozco, E. Rev. Saude. Publica (2006)
- Who pays more for health services in middle-income countries: lessons from Mexico. Arredondo, A., Nájera, P. Public. Health (2005)
- Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico. Arredondo, A., Zúñiga, A., Parada, I. Public. Health (2005)
- Evidences on weaknesses and strengths from health financing after decentralization: lessons from Latin American countries. Arredondo, A., Orozco, E., De Icaza, E. Int. J. Health. Plann. Manage (2005)
- The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Arredondo, A., Burke, T.A., Carides, G.W., Lemus, E., Querol, J. Rev. Invest. Clin. (2005)
- Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. Arredondo, A., Zúñiga, A. Diabetes. Care (2004)
